Natalie Munk Myriad Genetics Inc (MYGN) insider trading activity

Natalie Munk is Chief Accounting Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 43,259 shares of MYGN, which is worth approximately $670,081. The most recent transaction as insider was on Sep 21, 2024, when has been sold 964 shares (Common Stock) at a price of $27.64 per share, resulting in proceeds of $26,644. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.3K

2.66% 3M change

10.28% 12M change

Total Value Held $670,081

Natalie Munk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 21 2024	SELL Payment of exercise price or tax liability	$26,644 $27.64 p/Share	964 Reduced 2.18%	43,259 Common Stock
Aug 25 2024	SELL Payment of exercise price or tax liability	$6,102 $28.12 p/Share	217 Reduced 0.49%	44,223 Common Stock
Apr 06 2024	SELL Payment of exercise price or tax liability	$11,771 $20.26 p/Share	581 Reduced 1.29%	44,440 Common Stock
Mar 25 2024	SELL Payment of exercise price or tax liability	$7,978 $21.98 p/Share	363 Reduced 0.8%	45,021 Common Stock
Mar 24 2024	SELL Payment of exercise price or tax liability	$21,817 $22.24 p/Share	981 Reduced 2.12%	45,384 Common Stock
Mar 22 2024	SELL Payment of exercise price or tax liability	$8,073 $22.24 p/Share	363 Reduced 0.78%	46,365 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	7,500 Added 13.83%	46,728 Common Stock
Sep 21 2023	BUY Grant, award, or other acquisition	-	10,000 Added 20.31%	39,228 Common Stock
Aug 25 2023	SELL Payment of exercise price or tax liability	$3,858 $17.7 p/Share	218 Reduced 0.74%	29,228 Common Stock
Mar 25 2023	SELL Payment of exercise price or tax liability	$8,657 $23.72 p/Share	365 Reduced 1.2%	30,029 Common Stock
Mar 24 2023	SELL Payment of exercise price or tax liability	$23,411 $23.72 p/Share	987 Reduced 3.24%	29,446 Common Stock
Mar 22 2023	SELL Payment of exercise price or tax liability	$8,889 $22.91 p/Share	388 Reduced 1.24%	30,798 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	6,000 Added 16.14%	31,186 Common Stock
Aug 25 2022	SELL Payment of exercise price or tax liability	$5,476 $24.89 p/Share	220 Reduced 0.87%	25,186 Common Stock

Natalie Munk

Chief Accounting Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Value

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN

Account